| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |